Business & Impact
AlzAware is designed as a low-cost digital triage platform that helps older adults, families, clinics, and senior-care organizations recognize when professional cognitive evaluation may be worth considering.
Americans age 65 and older are estimated to be living with Alzheimer's dementia in 2026.
Projected U.S. health and long-term care costs for Alzheimer's and other dementias in 2026.
Projected annual U.S. dementia-related care costs by 2050 if the burden continues to rise.
Hours of unpaid caregiving were provided by family and friends in 2025.
Sources: Alzheimer's Association Facts and Figures and Public Health Approach to Alzheimer's.
The challenge
Alzheimer's disease is often recognized after years of subtle cognitive changes . Formal evaluation is important, but requires costly testing.
For many families, knowing when to get tested is crucial.
The opportunity
A low-cost digital reference tool can support earlier conversations, help prioritize limited clinical resources, and guide people toward appropriate professional evaluation.
A simple first step before higher-cost evaluation
AlzAware creates a low-friction triage layer. Users answer simple health and demographic questions, receive a model-based reference score, and see how that score compares with AD and non-AD study samples.
Accessible
Runs through a browser-based assessment and requires no specialized equipment.
Interpretable
Compares each result with reference score distributions instead of presenting an unsupported diagnosis.
Scalable
Can support families, clinics, senior-care facilities, and community health programs at very low cost.
Who pays and who benefits
The strongest early business path is B2B: serving organizations that already support older adults and need practical tools for cognitive risk awareness.
Resident screening
Facilities could subscribe per resident or per assessment to support routine cognitive risk check-ins and family communication.
Front-end triage
Primary-care clinics could use AlzAware to help identify patients who may need cognitive screening, specialist referral, or closer monitoring.
Future partnerships
Research groups and clinical-trial teams could use responsible pre-screening and longitudinal tracking to identify people for follow-up studies.
Economic potential
Dementia care represents a multi-hundred-billion-dollar annual burden in the United States. If a low-cost triage layer helped reduce even 1% of avoidable delays, inefficient navigation, or unnecessary friction against the projected 2026 cost burden, the implied system-level value would be roughly $4 billion.
It shows why scalable early-risk triage has meaningful public-health and economic potential.
Illustrative subscription scenario
A $3 per resident per month subscription across 100,000 monitored users would represent about $3.6M in annual recurring revenue.
From prototype to pilots
The next step is not immediate medical deployment. It is careful validation of usability, interpretation, and responsible follow-up workflows.
Prototype validation
Use the website, assessment page, and demo video to test whether users understand the score, comparison language, and medical disclaimer.
Senior-care and community pilots
Partner with senior-care facilities, caregiver groups, and community health programs to evaluate whether AlzAware improves early conversations and follow-up decisions.
Clinic and longitudinal expansion
Expand into primary-care settings and develop repeat assessments that track changes over time while preserving the boundary between risk awareness and diagnosis.